CenterWatch

Acromegaly Clinical Trials

A listing of Acromegaly medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter By:

 

California

Los Angeles California 90048

Patients are needed to participate in a clinical research study evaluating Sandostatin LAR for the treatment of Acromegaly

Maryland

Johns Hopkins University School of Medicine Division of Endocrinology, Diabetes & Metabolism
Baltimore Maryland 21287

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Massachusetts

Massachusetts General Hospital
Boston Massachusetts 02114

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

Boston Massachusetts 02114

A clinical trial seeking patients for a research study for the treatment of Acromegaly

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study for the treatment of Acromegaly

Michigan

University of Michigan Medical Center Rares de la Surrénale, Service d'Endocrinologie, Hôpital Cochin
Ann Arbor Michigan 48109

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

New Jersey

Basking Ridge New Jersey 07920

Patients are needed to participate in a clinical research study for the treatment of Acromegaly

New Mexico

UPDATED

University of New Mexico HSC
Albuquerque New Mexico 87131

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

New York

Icahn School of Medicine at Mount Sinai
New York New York 10029

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

New York New York 10032

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Ohio

Cleveland Clinic Endocrinology
Cleveland Ohio 44195

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

CarePoint East
Columbus Ohio 43203

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Oregon

Oregon Health & Science University
Portland Oregon

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Pennsylvania

University of Pennslyvania Smilow Center for Translational Research
Philadelphia Pennsylvania 19104-5160

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Tennessee

Nashville Tennessee 37212-8210

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Belgium

UZLeuven Dienst endocrinologie
Leuven International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

France

Endocrinologie, Pavillon des Ecrins Centre Hospitalier Universitaire, Hopital Nord
Cedex International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Hôpital de la TIMONE Department of Endocrinology and Reference Center for Rare Pituitary Diseases
Marseille International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Centre de Réference Maladies Rares de la Surrénale, Service d'Endocrinologie, Hôpital Cochin
Paris International 75014

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Israel

Institute of Endocrinology & Metabolism Rabin Medical Center, Beilinson Campus
Petah Tiqva International 49100

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Netherlands

Erasmus MC, Dpt. Of Internal Medicine, Division of Endocrinology Centre Hospitalier Universitaire, Hopital Nord
Rotterdam International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Spain

Hospital Universitario de la Ribera Centre Hospitalier Universitaire, Hopital Nord
Alzira-Valencia International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Hospital Sant Pau, Universitat Autònoma de Barcelona
Barcelona International 08025

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Australia

Darlinghurst New South Wales 2010

Patients are needed to participate in a clinical research study of Somatuline Autogel® (lanreotide) 60, 90, 120 mg. to evaluate Acromegaly

Fitzroy Victoria 3065

Patients are needed to participate in a clinical research study of Somatuline Autogel® (lanreotide) 60, 90, 120 mg. to evaluate Acromegaly

Heidelberg Victoria 3084

Patients are needed to participate in a clinical research study of Somatuline Autogel® (lanreotide) 60, 90, 120 mg. to evaluate Acromegaly

Herston Queensland 4006

Patients are needed to participate in a clinical research study of Somatuline Autogel® (lanreotide) 60, 90, 120 mg. to evaluate Acromegaly

St Leonards New South Wales 2065

Patients are needed to participate in a clinical research study of Somatuline Autogel® (lanreotide) 60, 90, 120 mg. to evaluate Acromegaly

View More ▼

Woolloongabba Queensland 4102

Patients are needed to participate in a clinical research study of Somatuline Autogel® (lanreotide) 60, 90, 120 mg. to evaluate Acromegaly

Austria

Vienna

A clinical trial to evaluate treatments using Somatuline Autogel® 60, 90 or 120 mg for patients with Acromegaly or Neuroendocrine Tumours

Belgium

Ghent 9000

A clinical research study for the treatment of Acromegaly

Canada

Montreal Quebec H2L 4M1

Patients are needed to participate in a clinical research study evaluating Alesse for the treatment of Acromegaly

Denmark

Aalborg 9000

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

France

Clermont-Ferrand 63000

A clinical trial seeking patients for a research study for the treatment of Acromegaly

Rouen cedex

A Phase 2 clinical study for patients with Acromegaly or Neuroendocrine Tumors

Germany

Hamburg

A clinical trial to evaluate treatments using Somatuline Autogel® 60, 90 or 120 mg for patients with Acromegaly or Neuroendocrine Tumours

Wuerzburg Bavaria 97080

A clinical trial seeking patients for a research study for the treatment of Acromegaly, Heart Failure or Hypertrophy, Left Ventricular

Italy

Genova

A Phase 2 clinical study for patients with Acromegaly or Neuroendocrine Tumors

Poland

Warszawa

A clinical trial seeking patients for a research study for the treatment of Acromegaly

Russian Federation

Moscow 119034

A clinical research study of Non-interventional cross-sectional survey for the treatment of Acromegaly

Moscow 119435

A clinical research study of Non-interventional cross-sectional survey for the treatment of Acromegaly

Saint-Petersburg 197341

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Switzerland

Basel

A clinical trial to evaluate treatments using Somatuline Autogel® 60, 90 or 120 mg for patients with Acromegaly or Neuroendocrine Tumours